Richard E Lowenthal Silverback Therapeutics, Inc. (SBTX) insider trading activity

SBTX Quotes by TradingView

Richard E Lowenthal is PRESIDENT AND CEO of Silverback Therapeutics, Inc.. Currently has a direct ownership of 4.32 Million shares of SBTX, which is worth approximately $0. The most recent transaction as insider was on Apr 19, 2024, when has been sold 188,491 shares (Common Stock) at a price of $1.14 per share, resulting in proceeds of $214,879. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.32M
0% 3M change
4.57% 12M change
Total Value Held $0

Richard E Lowenthal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 19 2024
BUY
Exercise of conversion of derivative security
$214,879 $1.14 p/Share
188,491 Added 4.19%
4,315,313 Common Stock
May 17 2023
SELL
Bona fide gift
-
1,050,000 Reduced 20.28%
4,126,822 Common Stock
Nov 08 2022
BUY
Grant, award, or other acquisition
-
5,176,822 Added 50.0%
5,176,822 Common Stock
REL

Richard E Lowenthal

PRESIDENT AND CEO
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX